The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cortical remyelination: A new target for repair therapies in multiple sclerosis
Open accessAbstract
OBJECTIVE: Generation and differentiation of new oligodendrocytes in demyelinated white matter is the best described repair process in the adult human brain. However, remyelinating capacity falters with age in patients with multiple sclerosis (MS). Because demyelination of cerebral cortex is extensive in brains from MS patients, we investigated the capacity of cortical lesions to remyelinate and directly compared the extent of remyelination in lesions that involve cerebral cortex and adjacent subcortical white matter. METHODS: Postmortem brain tissue from 22 patients with MS (age 27-77 years) and 6 subjects without brain disease were analyzed. Regions of cerebral cortex with reduced myelin were examined for remyelination, oligodendrocyte progenitor cells, reactive astrocytes, and molecules that inhibit remyelination. RESULTS: New oligodendrocytes that were actively forming myelin sheaths were identified in 30 of 42 remyelinated subpial cortical lesions, including lesions from 3 patients in their 70s. Oligodendrocyte progenitor cells were not decreased in demyelinated or remyelinated cortices when compared to adjacent normal-appearing cortex or controls. In demyelinated lesions involving cortex and adjacent white matter, the cortex showed greater remyelination, more actively remyelinating oligodendrocytes, and fewer reactive astrocytes. Astrocytes in the white matter, but not in cortical portions of these lesions, significantly upregulate CD44, hyaluronan, and versican, molecules that form complexes that inhibit oligodendrocyte maturation and remyelination. INTERPRETATION: Endogenous remyelination of the cerebral cortex occurs in individuals with MS regardless of disease duration or chronological age of the patient. Cortical remyelination should be considered as a primary outcome measure in future clinical trials testing remyelination therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although OPCs represent an available pool to replace lost oligodendrocytes and myelin, replacement is limited, particularly in cortical lesions (Chang et al. 2012).”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chang et al. 2012
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies in human post-mortem tissue and experimental models suggested that remyelination after a demyelinating insult is more efficient in the cerebral cortex compared to the white matter.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In patients with multiple sclerosis, remyelination has been observed in both white and grey matter and found to be more efficient in the cortex.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in human tissue and experimental models suggest that numerical and functional differences in oligodendrocyte lineage cells, as well as e.g. the phenotype of reactive astrogliosis, including a lower expression of CD44, versican and hyaluronan in the cortex, may play a role.15”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noseworthy, J. H., Lucchinetti, C. F., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 3,016
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L. S., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,458
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Self-citationPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Self-citationKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 216
Miedema, A., Wijering, M. H. C., Eggen, B. J. L., & Kooistra, S. M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.583811 · Cited by 24
Werkman, I. L., Sikkema, A. H., Versluijs, J. B., Qin, J., de Boer, P., & Baron, W. (2020) · Scientific Reports · doi:10.1038/s41598-019-57069-4 · Cited by 26
Du, B., Liang, M., Zheng, H., Fan, C., Zhang, H., Lu, X., Du, Z., Lian, Y., Zhang, Y., & Bi, X. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.011 · Cited by 26
Dysregulation of Hyaluronan Homeostasis During White Matter Injury
Srivastava, T., Sherman, L. S., & Back, S. A. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02879-1 · Cited by 26
Remyelination varies between and within lesions in multiple sclerosis following bexarotene
Brown, J. W. L., Prados, F., Altmann, D. R., Kanber, B., Stutters, J., Cunniffe, N. G., Jones, J., Georgieva, Z. G., Needham, E., Daruwalla, C., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51662 · Cited by 24
Oligodendrocyte lineage cells: Advances in development, disease, and heterogeneity
Wang, J., Gao, M.-Y., Gao, R., Zhao, K., Zhang, Y., & Li, X. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15728 · Cited by 24
Remyelinating strategies in multiple sclerosis
Luessi, F., Kuhlmann, T., & Zipp, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.969241 · Cited by 24
Cui, C., Wang, J., Mullin, A. P., Caggiano, A. O., Parry, T. J., Colburn, R. W., & Pavlopoulos, E. (2018) · Brain Research · doi:10.1016/j.brainres.2018.05.013 · Cited by 24
Wiggermann, V., Endmayr, V., Hernández‐Torres, E., Höftberger, R., Kasprian, G. J., Hametner, S., & Rauscher, A. (2023) · Brain Pathology · doi:10.1111/bpa.13150 · Cited by 22
Changes in structural network are associated with cortical demyelination in early multiple sclerosis
Mangeat, G., Badji, A., Ouellette, R., Treaba, C. A., Herranz, E., Granberg, T., Louapre, C., Stikov, N., Sloane, J. A., Bellec, P., et al. (2018) · Human Brain Mapping · doi:10.1002/hbm.23993 · Cited by 21
Werkman, I. L., Kövilein, J., de Jonge, J. C., & Baron, W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15113 · Cited by 23
Werkman, I. L., Dubbelaar, M. L., van der Vlies, P., de Boer-Bergsma, J. J., Eggen, B. J. L., & Baron, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02045-3 · Cited by 23
Remyelination in humans due to a retinoid‐X receptor agonist is age‐dependent
McMurran, C. E., Mukherjee, T., Brown, J. W. L., Michell, A. W., Chard, D., Franklin, R. J. M., Coles, A. J., & Cunniffe, N. G. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51595 · Cited by 22
Role of DAMPs and cell death in autoimmune diseases: the example of multiple sclerosis
Land, W. G. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00198-8 · Cited by 23
Kramann, N., Neid, K., Menken, L., Schlumbohm, C., Stadelmann, C., Fuchs, E., Brück, W., & Wegner, C. (2014) · Brain Pathology · doi:10.1111/bpa.12180 · Cited by 22
Petiet, A., Aigrot, M., & Stankoff, B. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00491 · Cited by 22
Skaper, S. D., Barbierato, M., Facci, L., Borri, M., Contarini, G., Zusso, M., & Giusti, P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0722-0 · Cited by 22
A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination
Preston, M., Finseth, L. T., Bourne, J. N., & Macklin, W. B. (2019) · Glia · doi:10.1002/glia.23559 · Cited by 23
Staugaitis, S. M., Chang, A., & Trapp, B. D. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12041 · Cited by 21
Self-citationAstrocyte phenotypes: Emphasis on potential markers in neuroinflammation.
Bozic, I. D., Savić, D. Z., & Lavrnja, I. C. (2021) · PubMed · doi:10.14670/hh-18-284 · Cited by 22
Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?
Ornelas, I. M., McLane, L. E., Saliu, A., Evangelou, A. V., Khandker, L., & Wood, T. L. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23900 · Cited by 22
Pinzón, N. E., Brevé, J. J. P., Bol, J. G. J. M., Drukarch, B., Baron, W., & van Dam, A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1031-2 · Cited by 22
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Dutta, R., Mahajan, K. R., Nakamura, K., Ontaneda, D., Chen, J. M., Volsko, C. M., Dudman, J., Christie, E., Dunham, J., Fox, R. J., et al. (2019) · Journal of Visualized Experiments · doi:10.3791/59511 · Cited by 20
Self-citationReversible Loss of Hippocampal Function in a Mouse Model of Demyelination/Remyelination
Das, A., Bastian, C., Trestan, L., Suh, J., Dey, T., Trapp, B. D., Baltan, S., & Dana, H. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00588 · Cited by 19
Self-citationA novel eye-movement impairment in multiple sclerosis indicating widespread cortical damage
Bijvank, J. A. N., Hof, S. N., Prouskas, S. E., Schoonheim, M. M., Uitdehaag, B. M. J., van Rijn, L. J., & Petzold, A. (2022) · Brain · doi:10.1093/brain/awac474 · Cited by 21
Structural adaption of axons during de‐ and remyelination in the Cuprizone mouse model
Pfeiffer, F., Frommer‐Kaestle, G., & Fallier‐Becker, P. (2019) · Brain Pathology · doi:10.1111/bpa.12748 · Cited by 22
Madsen, M. A. J., Wiggermann, V., Marques, M. F. M., Lundell, H., Cerri, S., Puonti, O., Blinkenberg, M., Christensen, J. R., Sellebjerg, F. T., & Siebner, H. R. (2022) · Brain · doi:10.1093/brain/awac203 · Cited by 20
Zuroff, L. R., Farkhondeh, V., Bove, R. M., & Green, A. (2025) · Drugs · doi:10.1007/s40265-025-02212-x · Cited by 20
Riboni-Verri, G., McMurran, C. E., Mukherjee, T., Daruwalla, C., Holland, J., Gautam, R., Chen, B. S., Cutting, E., Qian, W., MacManus, D. G., et al. (2025) · Trials · doi:10.1186/s13063-025-09254-2 · Cited by 18
Feliú, A., Mestre, L., Carrillo-Salinas, F. J., Yong, V. W., Mecha, M., & Guaza, C. (2020) · Glia · doi:10.1002/glia.23775 · Cited by 18
Self-citationBCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis
Bergner, C. G., van der Meer, F., Franz, J., Vakrakou, A., Würfel, T., Nessler, S., Schäfer, L., Nau-Gietz, C., Winkler, A., Lagumersindez-Denis, N., et al. (2025) · Brain · doi:10.1093/brain/awae293 · Cited by 16
“15 Also, oligodendrocyte precursor cells in cortex and white matter were shown to differ in their propensity for terminal differentiation, and cortical oligodendrocytes reach their final number much later in life than in the white matter, as inferred from 14 C incorporation.”
Heaven, M. R., Herren, A. W., Flint, D., Pacheco, N. L., Li, J., Tang, A., Khan, F., Goldman, J. E., Phinney, B. S., & Olsen, M. L. (2021) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2021.100180 · Cited by 17
Louapre, C., Govindarajan, S. T., Giannì, C., Cohen‐Adad, J., Gregory, M. D., Nielsen, A. S., Madigan, N. K., Sloane, J. A., Kinkel, R. P., & Mainero, C. (2015) · Radiology · doi:10.1148/radiol.2015150486 · Cited by 16
Hosseinpour, Z., Jonkman, L. E., Oladosu, O., Pridham, G., Pike, G. B., Inglese, M., Geurts, J. J. G., & Zhang, Y. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109671 · Cited by 17
Lazzarotto, A., Tonietto, M., Poirion, E., Battaglini, M., Palladino, R., Benoit, C., Ricigliano, V., Maillart, E., de Stefano, N., Stankoff, B., et al. (2022) · Multiple Sclerosis · doi:10.1177/13524585221096975 · Cited by 11
H2S-RhoA/ROCK Pathway and Glial Cells in Axonal Remyelination After Ischemic Stroke
Lu, W., & Wen, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03422-8 · Cited by 15
Therapeutic Application of Monoclonal Antibodies in Multiple Sclerosis
Orthmann‐Murphy, J. L., & Calabresi, P. A. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.547 · Cited by 15
Multiple Sclerosis: Glial Cell Diversity in Time and Space
Kooistra, S. M., & Schirmer, L. (2024) · Glia · doi:10.1002/glia.24655 · Cited by 14
Automated in vivo Tracking of Cortical Oligodendrocytes
Xu, Y. K. T., Call, C. L., Sulam, J., & Bergles, D. E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.667595 · Cited by 13
p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions
Marziali, L. N., Hwang, Y., Palmisano, M., Cuenda, A., Sim, F. J., Gonzalez, A., Volsko, C. M., Dutta, R., Trapp, B. D., Wrabetz, L. G., et al. (2023) · Brain · doi:10.1093/brain/awad421 · Cited by 13
Self-citationKumar, N., Singh, V. P., Li, L., Willard, B. B., Tripathi, A. K., & Dutta, R. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.779003 · Cited by 14
Self-citationMicroglia and Multiple Sclerosis
Hammond, B. P., Panda, S. P., Kaushik, D. K., & Plemel, J. R. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_25 · Cited by 11
Schwann Cell Remyelination in the Multiple Sclerosis Central Nervous System
Ghezzi, L., Bollman, B., Feo, L. D., Piccio, L., Trapp, B., Schmidt, R. E., & Cross, A. (2023) · Laboratory investigation; a journal of technical methods and pathology · doi:10.1016/j.labinv.2023.100128 · Cited by 10
Self-citationThe association between multiple sclerosis and spondylosis: When and why
Xydis, V. G., Zikou, A. K., Kostadima, V., Astrakas, L. G., Kosta, P., & Argyropoulou, M. I. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.03.017 · Cited by 11
Ontogenetic oligodendrocyte maturation through gestational iron deprivation: The road not taken
Guitart, M. E., Vence, M., Correale, J. D., Pasquini, J. M., & Rosato‐Siri, M. V. (2019) · Glia · doi:10.1002/glia.23647 · Cited by 11
Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model
Zerimech, S., Nguyen, H., Vandenbark, A. A., Offner, H., & Baltan, S. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1237078 · Cited by 10
Scalabrino, G. (2022) · Biomedicines · doi:10.3390/biomedicines10040815 · Cited by 10
Chomyk, A., Kucinski, R., Kim, J., Christie, E., Cyncynatus, K., Gossman, Z., Chen, Z., Richardson, B., Cameron, M., Turner, T., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26877 · Cited by 9
Self-citationMultiple sclerosis: new measures to monitor the disease
Filippi, M., & Rocca, M. A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70288-0 · Cited by 9
Spring cleaning: time to rethink imaging research lines in MS?
Absinta, M., Reich, D. S., & Filippi, M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8060-0 · Cited by 10
Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target?
Silva, B. A., & Ferrari, C. C. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0017 · Cited by 10
Szekely-Kohn, A. C., Castellani, M., Espino, D. M., Baronti, L., Ahmed, Z., Manifold, W. G. K., & Douglas, M. (2025) · Royal Society Open Science · doi:10.1098/rsos.241052 · Cited by 12
Geloso, M. C., Ria, F., Corvino, V., & Sante, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178223 · Cited by 9
T1/T2-weighted ratio is a surrogate marker of demyelination in multiple sclerosis—yes
Nakamura, K., Zheng, Y., & Ontaneda, D. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585211066313 · Cited by 7
Mi, X.-J., Li, J., Feng, Z., Liu, Y., Zhang, C., Shao, Y., Wang, T., Yang, Z., Lv, H., & Liu, J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108312 · Cited by 7
Multiple sclerosis: what have we learned and can we still learn from electron microscopy
Oost, W., Meilof, J. F., & Baron, W. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05690-0 · Cited by 7
Gingele, S., Möllenkamp, T. M., Henkel, F., Schröder, L., Hümmert, M. W., Skripuletz, T., Stangel, M., & Gudi, V. (2023) · Brain Pathology · doi:10.1111/bpa.13218 · Cited by 7
Cortical projection neurons as a therapeutic target in multiple sclerosis
Beutel, T., Dzimiera, J., Kapell, H., Engelhardt, M., Gass, A., & Schirmer, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1842358 · Cited by 7
Demyelinated lesion associated compartmental inflammation in progressive multiple sclerosis brains
Najm, L., Chomyk, A. M., Cyncynatus, K., Davalos, D., Mahajan, K. R., & Trapp, B. D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02122-9 · Cited by 6
Self-citationA Therapeutic Link between Astrogliosis and Remyelination in a Mouse Model of Multiple Sclerosis
Pearson, C. S. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2844-17.2017 · Cited by 6
The cortical blood–brain barrier in multiple sclerosis: a gateway to progression?
Bell, J. S., Spencer, J. I., Yates, R. L., & DeLuca, G. C. (2018) · Journal of Neurology · doi:10.1007/s00415-017-8727-1 · Cited by 6
Ageing and remyelination failure in people with multiple sclerosis
Mukherjee, T., McMurran, C. E., Holland, J., Daruwalla, C., Riboni-Verri, G., Brown, J. W. L., Franklin, R. J. M., Coles, A. J., & Cunniffe, N. G. (2025) · Brain · doi:10.1093/brain/awaf373 · Cited by 6
Myelination potential and injury susceptibility of grey versus white matter human oligodendrocytes
Cui, Q., Mohammadnia, A., Yaqubi, M., Weng, C., Dorion, M., Pernin, F., Hall, J. A., Dudley, R., Stratton, J. A., Kennedy, T. E., et al. (2024) · Brain · doi:10.1093/brain/awae311 · Cited by 5
Recent developments in multiple sclerosis neuropathology
Stadelmann, C., Franz, J., & Nessler, S. (2025) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001370 · Cited by 6
Dutta, R. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513500554 · Cited by 5
Self-citationŠťastná, D., Menkyová, I., & Horáková, D. (2023) · Neurologie pro praxi · doi:10.36290/neu.2022.068 · Cited by 5
Rosato‐Siri, M. V., Adami, P. V. M., Guitart, M. E., Verstraeten, S. V., Morelli, L., Correale, J. D., & Pasquini, J. M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03149-y · Cited by 4
The Future of PET Imaging in Multiple Sclerosis: Characterisation of Individual White Matter Lesions
van der Weijden, C. W. J., Meilof, J. F., van der Hoorn, A., de Vries, E. F. J., & Baron, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134439 · Cited by 4
PART 2: Mouse models for multiple sclerosis research
Ramasamy, R., & Smith, P. P. (2021) · Neurourology and Urodynamics · doi:10.1002/nau.24654 · Cited by 4
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Dutta, R., Mahajan, K. R., Nakamura, K., Ontaneda, D., Chen, J. M., Volsko, C. M., Dudman, J., Christie, E., Dunham, J., Fox, R. J., et al. (2019) · Journal of Visualized Experiments · doi:10.3791/59511-v · Cited by 4
Self-citationCortical remyelination in multiple sclerosis: a target for disease monitoring and intervention
Mainero, C., Miscioscia, A., & Treaba, C. A. (2024) · Brain · doi:10.1093/brain/awae083 · Cited by 4
Quantitative T1 is sensitive to cortical remyelination in multiple sclerosis: A postmortem MRI study
Galbusera, R., Weigel, M., Bahn, E., Schaedelin, S. A., Cagol, A., Lu, P., Baraković, M., Melie‐García, L., Franz, J., Dechent, P., et al. (2025) · Brain Pathology · doi:10.1111/bpa.70010 · Cited by 3
The mechanism of disease progression by aging and age-related gut dysbiosis in multiple sclerosis
Yadav, S. K., Chen, C., Dhib-Jalbut, S. S., & Ito, K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106956 · Cited by 4
Etemadifar, M., Rezaei, K., Hojjatipour, F., & Salari, M. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106569 · Cited by 4
Precision in a sea of profusion: Myelin replacement triggered by single-cell cortical demyelinationPreprint
Snaidero, N., Schifferer, M., Mężydło, A., Kerschensteiner, M., & Misgeld, T. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.16.877597 · Cited by 3
Remyelination restores myelin content on distinct neuronal subtypes in the cerebral cortexPreprint
Call, C. L., & Bergles, D. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.17.431685 · Cited by 3
Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination
Loo, H. K., Gallegos, J., Mialki, C., Perrin, G. E., Malloy, T., & Orthmann‐Murphy, J. L. (2026) · Glia · doi:10.1002/glia.70120 · Cited by 2
“Although OPCs represent an available pool to replace lost oligodendrocytes and myelin, replacement is limited, particularly in cortical lesions (Chang et al. 2012).”
Ferreira, C., Carvalho, F. S., Vieira, P., Alves, A. D. C., Palavra, F., Almeida, J., Alves, V., Coscueta, E. R., Dias‐Pereira, P., Pintado, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682183 · Cited by 2
Much, if not all, of the cortical damage in MS can be attributed to the microglial cell – No
Dutta, R., & Trapp, B. D. (2018) · Multiple Sclerosis Journal · doi:10.1177/1352458517743094 · Cited by 2
Self-citationOligodendrocyte Progenitor Cell Cultures: A Model to Screen Neurotrophic Compounds for Myelin Repair
Barbierato, M., Skaper, S. D., & Facci, L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7571-6_12 · Cited by 2
Song, J., Wang, J., Li, Y., Wang, H., Li, M., Huang, F., Zhang, X., Wan, D., Ye, J.-H., Zhou, K., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1750555 · Cited by 1
Kooi, E. (2013) · Neuropraxis · doi:10.1007/s12474-013-0019-7 · Cited by 1
Cortical Involvement in Multiple Sclerosis
Bannerman, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00010-0 · Cited by 1
Pathologie und Immunpathogenese der Multiplen Sklerose
Stadelmann, C. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1766-8_2 · Cited by 2
Bernal‐Chico, A., Manterola, A., & Mato, S. (2020) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21355
Cunniffe, N. (2021) · Apollo (University of Cambridge) · doi:10.17863/cam.77136 · Cited by 1
Quantitative MRI and histopathology detect remyelination in inactive multiple sclerosis lesionsPreprint
Wiggermann, V., Endmayr, V., Hernández‐Torres, E., Höftberger, R., Kasprian, G. J., Hametner, S., & Rauscher, A. (2022) · medRxiv · doi:10.1101/2022.08.01.22271457 · Cited by 1
Jürgens, T. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3904
The ‘best’ basic science paper on multiple sclerosis in 2012
Mahad, D. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513486520
The best basic science paper on multiple sclerosis in 2012: Commentary
Hutchinson, M. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513495940
Immunopathogenesis of cortical demyelination in Multiple Sclerosis
Lagumersindez-Denis, N. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5375
Vignos, M. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
On the role of macrophages, microglia and the extracellular matrix in remyelination
Wang, P. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Microfiber platform for oligodendrocyte myelination
Ong, W. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136941
Filley, C. M. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781139548878.015
Lyons, D. A., & Almeida, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738031512.793575106
Сучасні механізми та стратегії фармакотерапії ремієлінізації при розсіяному склерозі
Нефьодов, О. О., Kalbus, O. I., & Ларіонов, В. Б. (2022) · Український медичний часопис · doi:10.32471/umj.1680-3051.149.229066
Bouman, P. M. (2023) · doi:10.5463/thesis.137
Metadata
- Authors
- Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D.
- Affiliations
- Cleveland Clinic (US)
- University of Calgary (CA)
- Corresponding author
- Trapp, Bruce D.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-10-17
- Volume
- 72
- Issue
- 6
- Pages
- 918-926
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3535551
- OpenAlex
- W2061522969
- Cited by
- 216
- References
- 42
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 10 · 2023: 19 · 2022: 22 · 2021: 16 · 2020: 18 · 2019: 23 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 16 · 2014: 13 · 2013: 13 · 2012: 2
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Multiple Sclerosis Society
- Cleveland Clinic
- National Institutes of Health (UL1TR000439)
- University of California, Davis
- National Institute of Neurological Disorders and Stroke (NS38867, P50NS038667)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple sclerosis, demyelination, oligodendrocyte precursor cells, reactive astrocytes, CD44, hyaluronic acid, versican, oligodendrocyte maturation, white matter lesions, remyelination therapy
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Adult, Aged, Antigens, Cerebral Cortex, Demyelinating Diseases, Female, Glial Fibrillary Acidic Protein, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Postmortem Changes, Proteoglycans, Regeneration, RNA, Messenger, Hyaluronan Receptors, Myelin Proteolipid Protein, Adaptor Proteins, Signal Transducing, Adult Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
